Bicycle Therapeutics (BCYC)
(Delayed Data from NSDQ)
$24.58 USD
-0.11 (-0.45%)
Updated May 3, 2024 04:00 PM ET
After-Market: $24.58 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $-1.26 | 13.77% |
Earnings Summary
For their last quarter, Bicycle Therapeutics (BCYC) reported earnings of -$0.62 per share, beating the Zacks Consensus Estimate of $-1.26 per share. This reflects a positive earnings surprise of 50.79%. Look out for BCYC's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$1.26 per share, reflecting a year-over-year increase of 10.64%.
Earnings History
Price & Consensus
Zacks News for BCYC
Bicycle (BCYC) to Begin Pivotal Bladder Cancer Study, Stock Up
BCYC: What are Zacks experts saying now?
Zacks Private Portfolio Services